Latest Cancer: Prostate news
Appropriate Duration of ADT in Prostate Cancer Depends on Risk
posted December 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Enzalutamide + Leuprolide Boosts Overall Survival for Prostate Cancer With High Recurrence Risk
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Niraparib Plus AAP Improves Survival in mCSPC With HRR Gene Alterations
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Electroacupuncture Accelerates Postprostatectomy Urinary Continence Recovery
posted October 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 .jpeg)
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer 
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer Related Articles
Focal Therapy Use Remains Uncommon in Nonmetastatic Prostate Cancer 
Risk for Prostate Cancer Elevated With Higher Ultraprocessed Food Intake 
Rates of Active Surveillance for Low-Risk Prostate Cancer High for Veterans 
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer Monthly Specialist Briefings
Stay Connected
